New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1.8 mg/ml;   - solution for injection - 1:1000 - active: adrenaline acid tartrate 1.8 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 0.182 mg/ml;   - solution for injection - 1:10000 - active: adrenaline acid tartrate 0.182 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline 0.1 mg/ml (1:10,000) - solution for injection - 0.1 mg/ml - active: adrenaline 0.1 mg/ml (1:10,000) excipient: citric acid monohydrate hydrochloric acid sodium bisulfite sodium chloride sodium citrate dihydrate water for injection - adjunctive use in the management of cardiac arrest.

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - adrenaline 1:1000 (1mg/ml);   - solution for injection - 1 mg/ml - active: adrenaline 1:1000 (1mg/ml)   excipient: citric acid monohydrate hydrochloric acid sodium bisulfite sodium chloride sodium citrate dihydrate water for injection

Ireland - English - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - noradrenaline acid tartrate - 0.1 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - adrenaline (epinephrine), quantity: 0.3 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium metabisulfite; hydrochloric acid - for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, or bites, foods, drugs or other allergens.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - adrenaline (epinephrine), quantity: 0.15 mg - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; hydrochloric acid; water for injections - for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, or bites, foods, drugs or other allergens.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

0.25%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules (advanz pharma - bupivacaine hydrochloride; adrenaline acid tartrate - solution for injection - 2.5mg/1ml ; 5microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

0.5%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules (advanz pharma - bupivacaine hydrochloride; adrenaline acid tartrate - solution for injection - 5mg/1ml ; 5microgram/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.